Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer.

Anthony J BazzanGeorge ZabreckyNancy WinteringAndrew B NewbergDaniel A Monti

Published in: Integrative cancer therapies (2018)

The results of this retrospective analysis support the growing evidence that IV AA is generally safe and well tolerated in patients with cancer, and may be useful in symptom management and improving quality of life.

Keyphrases

high dose
cross sectional
low dose